FINETECH INDUSTRY LIMITED

High-Quality CTLA-4 Inhibitor (CAS: 635324-72-0) – Available at Finetech Industry Limited

🔬 Advancing Immunotherapy Research with CTLA-4 Inhibitors 🔬At Finetech Industry Limited, we are committed to providing high-purity research chemicals for cutting-edge scientific advancements. One of our key offerings is CTLA-4 Inhibitor (CAS: 635324-72-0), a promising compound in the field of immunotherapy and oncology research.Product Details🔹 Chemical Name: 2-(4-fluorophenyl)-6-methyl-4-(3-(trifluoromethyl)phenyl)-1,2-dihydrodipyrazolo[3,4-b:3',4'-d]pyridin-3(6H)-one🔹 CAS Number: 635324-72-0🔹 Purity: High-purity, research-grade🔹 Application: Immuno-oncology, autoimmune disease research, and [...]

Mar 11, 2026 Product News 555 Views Read More

N-(6-Aminohexyl)acetamide Cas:49631-88-1: Properties and Potential Applications

Introduction:N-(6-Aminohexyl)acetamide is a chemical compound belonging to the class of acetamides. It is characterized by the presence of a 6-aminohexyl group attached to the nitrogen atom of the acetamide structure. This article provides an overview of the properties and potential applications of N-(6-Aminohexyl)acetamide.Chemical Properties:N-(6-Aminohexyl)acetamide has a molecular formula of C8H18N2O and a molecular weight of approximately 158.24 g/mol. It is a white to off-white crystalline solid with a characteristic odor. The compound is soluble in water and organic solvents such as eth [...]

Mar 11, 2026 Product News 1523 Views Read More

Idarubicin: Mechanism of Action, Side Effects, and Clinical Applications in Cancer Treatment

Idarubicin 57852-57-0is a potent chemotherapy drug belonging to the anthracycline class, primarily used in the treatment of various types of cancer, including acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL). Its mechanism of action, side effects, and clinical applications make it a crucial component of cancer treatment regimens.Mechanism of Action:Idarubicin exerts its anticancer effects by interfering with the DNA and RNA synthesis of cancer cells. It does so by intercalating between DNA base pairs, inhibiting the activity of topoisomerase II enzyme, and generating free radi [...]

Mar 11, 2026 Product News 1237 Views Read More